N@N

NKSH, ANGO, CBST, INDB, MTOX, OPTT Expected To Be Up After Next Earnings Releases

^{Published on 2011-07-13 05:30:07 - WOPRAI}
 

July 13, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, July 14th 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and July earnings reports. NATIONAL BANKSHARES INC/VA (NASDAQ:NKSH), ANGIODYNAMICS INC (NASDAQ:ANGO), CUBIST PHARMACEUTICALS INC (NASDAQ:CBST), INDEPENDENT BANK CORP/MA (NASDAQ:INDB), MEDTOX SCIENTIFIC INC (NASDAQ:MTOX), OCEAN POWER TECHNOLOGIES INC (NASDAQ:OPTT) are all expected to be Up After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Thursday:

     Symbol     Company                             # of Reports            Quarter     Release Time
     NKSH       NATIONAL BANKSHARES INC/VA          July Earnings           Q2          After
     ANGO       ANGIODYNAMICS INC                   6 Quarter               Q4          After
     CBST       CUBIST PHARMACEUTICALS INC          July Earnings           Q2          After
     INDB       INDEPENDENT BANK CORP/MA            6 Quarter               Q2          After
     MTOX       MEDTOX SCIENTIFIC INC               12 Quarter              Q2          Before
     OPTT       OCEAN POWER TECHNOLOGIES INC        12 Quarter              Q4          Before

NATIONAL BANKSHARES INC/VA (NASDAQ:NKSH) - National Bankshares, Inc. operates as the bank holding company for the National Bank of Blacksburg that provides a range of retail and commercial banking services to individuals, businesses, non profits, and local governments in Virginia. It accepts various deposit products, including demand deposits, money market deposit accounts, savings accounts, and certificates of deposit. The companys loan portfolio comprises commercial, agricultural, real estate, home equity, and consumer loans. It also offers merchant credit card services, business and consumer credit cards, letters of credit, night depository, safe deposit boxes, travelers checks, utility payment services, and automatic funds transfer services. In addition, the company provides wealth management, and trust and estate services for individual and business customers, as well as offers telephone and Internet banking services. It operates 24 branch offices and 25 automated teller machines in southwest Virginia. Further, the company, through its subsidiary, National Bankshares Financial Services, Inc., offers non-deposit investment products and insurance products. National Bankshares was founded in 1891 and is headquartered in Blacksburg, Virginia.

ANGIODYNAMICS INC (NASDAQ:ANGO) - AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat peripheral vascular disease, tumors, and other non-coronary diseases. It operates in three segments: Peripheral Vascular, Access, and Oncology/Surgery. The Peripheral Vascular segment offers and manages venous, angiographic, percutaneous transluminal angioplasty (PTA), drainage, thrombolytic, targeted renal therapy, micro access, and transjugular access product lines. Its venous products include VenaCure and Sotradecol products; angiographic product line comprises angiographic catheters, entry needles, guidewires, and fluid management products; PTA product line consists of PTA dilation balloon catheters, including WORKHORSE and PROFILER to open blocked blood vessels and dialysis access sites; drainage product line includes TOTAL ABSCESSION general drainage catheters; and thrombolytic product line comprises PULSE SPRAY, UNI FUSE, and SPEEDLYSER catheters. The Access segment provides and manages dialysis, port, and PICC product lines. Its dialysis product line includes dialysis catheters, which are marketed under the DuraMax, SCHON, EVENMORE, DURA-FLOW, SCHON XL, and LIFEJET F-16 brands. The Oncology/Surgery segment offers radio frequency ablation products, which include radiofrequency ablation (RFA) disposable electrodes, RF resection device, and RFA generators; embolization products; and NanoKnife products, based on the principles of Irreversible Electroporation. The company offers its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Queensbury, New York.

CUBIST PHARMACEUTICALS INC (NASDAQ:CBST) - Cubist Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides in the United States. It also promotes MERREM I.V. (meropenem for injection) in the U.S. under an agreement with AstraZeneca Pharmaceuticals, LP. The companys clinical product pipeline consists of ecallantide, a recombinant human protein being developed for the reduction of blood loss during cardiac surgery, for which Phase 2 data is under analysis; a Phase 2 program focused on the development of a novel cephalosporin to address certain serious infections caused by multi-drug resistant (MDR) Gram-negative organisms; a program for the treatment of CDAD (Clostridium difficile-associated diarrhea), which is entering Phase 2; and a Phase 1 program to address the unmet medical need for a treatment for serious infections caused by MDR Gram-negative pathogens. Cubist Pharmaceuticals is also working on various pre-clinical programs, including an anti-infective program for the treatment of respiratory syncytial virus (RSV) in children, therapies to treat various serious bacterial infections, and agents to treat acute pain. It has a collaboration agreement with Alnylam Pharmaceuticals, Inc. for developing Alnylams RNA interference to treat RSV. The company was founded in 1992 and is headquartered in Lexington, Massachusetts.

INDEPENDENT BANK CORP/MA (NASDAQ:INDB) - Independent Bank Corp. operates as the bank holding company for Rockland Trust Company that provides commercial and retail banking, and wealth management services in Massachusetts. It generates various deposit products, including demand deposits, interest checking accounts, savings accounts, money market accounts, and time certificates of deposit. The companys loan portfolio comprises commercial loans, which include loans to businesses for working capital and other business-related purposes, and floor plan financing; small business loans that consist of loans to businesses with commercial credit needs; and consumer loans, which comprise installment loans, personal loans, automobile loans, and overdraft protection. It also provides real estate loans, which include commercial mortgages that are secured by non-residential properties; residential mortgages, which are secured primarily by owner-occupied residences; mortgages for the construction of commercial and residential properties; and home equity loans and lines. In addition, the company offers investment management and trust services to individuals, small businesses, and charitable institutions. As of December 31, 2009, it operated 68 full service and 3 limited service retail branches, 11 commercial banking centers, 4 investment management offices, and 4 mortgage lending centers in the in eastern Massachusetts; and Lincoln, Rhode Island. The company was founded in 1907 and is headquartered in Rockland, Massachusetts.

MEDTOX SCIENTIFIC INC (NASDAQ:MTOX) - MEDTOX Scientific, Inc. and its subsidiaries provide forensic and clinical laboratory services. The company also manufactures and distributes diagnostic and related devices. Its Laboratory Services segment offers drugs-of-abuse testing services. It also provides clinical and other laboratory services, including clinical toxicology, clinical testing for occupational health clinics, clinical testing for physician offices, pediatric lead testing, and analysis of heavy and trace metal. In addition, this segment offers services in the area of logistical support, data management, and program management; and pain management products. Further, it provides clinical trial services comprising central laboratory, assay (test) development, bio-analytical, bio-equivalence, and pharmacokinetic testing services for pharmaceutical and biotech companies, clinical research organizations, research organizations, investigators with trial management, and patient recruitment/enrollment and site management organizations. The companys Product Sales segment offers point-of-collection testing (POCT) products for drugs-of-abuse. It primarily provides diagnostic drug screening products, such as PROFILE-II ER and PROFILE-III ER, and PROFILE-IV to hospital markets for drug detection in patients; MEDTOXScan, an electronic reader for use with PROFILE-V device in hospital laboratories and emergency rooms; and VERDICT-II and SURE-SCREEN diagnostic drug screening products for criminal justice and drug rehabilitation markets. This segment also offers coagulation/blood clotting market controls; and distributes diagnostic tests for the detection of alcohol with the EZ-SCREEN Breath Alcohol Test. The company serves public and private companies, drug treatment counseling centers, criminal justice facilities, occupational health clinics, third party administrators, and hospitals. MEDTOX Scientific, Inc. was founded in 1983 and is based in St. Paul, Minnesota.

OCEAN POWER TECHNOLOGIES INC (NASDAQ:OPTT) - Ocean Power Technologies, Inc. engages in the development and commercialization of proprietary systems that generate electricity by harnessing the renewable energy of ocean waves primarily in North America, Europe, and Australia. Its product portfolio includes utility PowerBuoy system to supply electricity to a local or regional electric power grid; and autonomous PowerBuoy system that is designed to generate power for use independent of the power grid in remote locations. The companys autonomous PowerBuoy system is also used for sonar and radar surveillance, tsunami warning, oceanographic data collection, offshore platforms, and offshore aquaculture applications. Its customers include public utilities, independent power producers, and other governmental entities and agencies. The company was incorporated in 1984 and is headquartered in Pennington, New Jersey.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641